跳至主要内容
临床试验/CTRI/2023/04/051952
CTRI/2023/04/051952尚未招募Unknown

A Prospective Randomised Study To Evaluate Efficacy And Safety between Two Different Dose Fractionation Schedule Of Interstitial Brachytherapy In Treatment Of Patients With Carcinoma of Uterine Cervix

SVIMS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
SVIMS

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Histopathologically confirmed carcinoma of Uterine cervix
  • Patients of age group 18 to 70 years.
  • Patients with performance status of 0 to 2
  • Stage II B- III C with intact cervix.
  • Patients with gross residual disease after EBRT not suitable for ICRT
  • Distorted Geometry like narrow vagina and os not soundable
  • Post hysterectomy Carcinoma vault
  • Post supra cervical hysterectomy with carcinoma of cervical stump.
  • Extensive para vaginal and distal vaginal involvement
  • Patients who has given approved informed consent
  • Post EBRT parametrial involvement of more than medial one third

排除标准

  • Patients with distant metastasis
  • Patients with prior EBRT and Brachytherapy to pelvis
  • Patients with ECOG performance status of 3-4
  • Pregnant women and lactating mothers
  • Patients who has not given informed consent

研究者

发起方
SVIMS

相似试验